Ładuje się......
Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?
Severe refractory asthma is characterized by a higher risk of asthma-related symptoms, morbidities, and exacerbations. This disease also determines much greater healthcare costs and deterioration in health-related quality of life (HR-QoL). Another concern, which is currently much discussed, is the h...
Zapisane w:
| Wydane w: | Drugs Context |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioExcel Publishing Ltd
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6469746/ https://ncbi.nlm.nih.gov/pubmed/31024635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212580 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|